Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Evoke Pharma - 11 Year Stock Split History | EVOK

Stock split history for Evoke Pharma since 2013. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
  
Evoke Pharma Annual Stock Splits
Evoke Pharma Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.008B $0.005B
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $24.142B 7.92
Dr Reddy's Laboratories (RDY) India $12.621B 24.15
BridgeBio Pharma (BBIO) United States $4.953B 0.00
Bausch Health Cos (BHC) Canada $2.672B 1.97
Supernus Pharmaceuticals (SUPN) United States $1.975B 26.90
Amphastar Pharmaceuticals (AMPH) United States $1.894B 11.38
Taysha Gene Therapies (TSHA) United States $0.379B 26.43
Personalis (PSNL) United States $0.372B 0.00
Assembly Biosciences (ASMB) United States $0.100B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Teligent (TLGT) United States $0.000B 0.00